2017 Annual Scientific Meeting

September 16-19, 2017 | Dallas, Texas

Watch all of the great educational content from the 21st Annual Scientific Meeting, anytime and anywhere! Annual Scientific Meeting OnDemand 2017 provides you complete access to the program, which includes basic science, translational and clinical science. For more information, click on the button below.

The Heart Failure Society of America designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.75 MOC points in the Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

PHARMACISTS

The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Pharmacists may earn up to 20.50 hours of knowledge-based CPE. To earn credit, participants must use the 5-digit code provided at the end of each accredited presentation to access the online program evaluations posted on ipharmCE.UCDenver.edu. Once evaluations are completed, CPE will be uploaded to CPE monitor within 2 days.

Information for Pharmacists

Only the topics listed below are accredited for continuing pharmacy education. The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Pharmacists may earn up to 20.50 hours of knowledge-based CPE. To earn credit, participants must use the 5-digit code provided at the end of each accredited presentation to access the online program evaluations posted on ipharmCE.UCDenver.edu. Once evaluations are completed, CPE will be uploaded to CPE monitor within 2 days.

This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) This activity is approved for 24.25 contact hours. Approval through 09/12/2019; ONA #21084

Please call HFSA at 301-312-8635 for more information about contact hours.

Satellite Symposia

Master Class on Heart Failure: Implementing Real-World Experience and New Advances to Reduce Hospitalizations and Costs This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) This activity is approved for 2 contact hours. Approval through 09/12/2019; ONA # 21112

Cardiac Amyloidosis: Stop Missing It! A Multi-Disciplinary Approach to a Not So Rare DiseaseThis continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) This activity is approved for 1.5 contact hours. Approval through 09/12/2019; ONA #21105

Discussing the Impact of Hyperkalemia on Management Strategies for Patients with Heart Failure: A Town Hall Forum This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) This activity is approved for 1.0 contact hours. Approval through 09/12/2019; ONA #21104

For those certified with ANCC and interested in obtaining pharmacology hour credits, 60 minutes of pharmacology content equal one contact hour. Please keep the conference agenda pertaining to the pharmacology session and keep on file for future reference. This may be submitted and serve as evidence to validate the contact hour calculation. A narrative note describing pharmacology content within agenda may be necessary to validate content. Pharmacotherapeutic content does not need to be presented by a nurse for the hours to be eligible for re-certification; however, the presenter must have content expertise in pharmacology.

EvaluationsAn evaluation must be completed in order to receive a credit certificate for the scientific meeting or for satellite symposia. All evaluations will be electronic and will be formatted for smart phones, tablets and computers. They can also be accessed using the CE kiosks in the registration area.

Physicians & NursesPhysician and nursing continuing education credit certificates for the scientific meeting and for satellite symposia can be requested on-site using smart phones, tablets, computers, or the CE kiosks in the registration area.

Certificates will be issued only to individuals registered for the Annual Scientific Meeting. If necessary, attendance will be verified based on information collected by hand-held scanners at meeting room entrances.

For more information regarding continuing education certification and credits, refer to your Program or visit the official meeting app for more details.

Pharmacists will need to create a profile on iPharmCE to access evaluations and claim CPE credit. If you don’t have an account already, create one by entering a valid email address under New Account Sign‐up, and following the on‐screen instructions. Once logged in, click Complete Live Activity Post‐tests and Evaluations on the left side of the screen, scroll down to the group titled HFSA 2017, and select the presentation title.

CPE Credit for each presentation will be uploaded to CPE Monitor upon completion of the evaluation. General instructions on how to access the online evaluation platform will also be emailed to pharmacists who sign‐in after the program.

Barry H. Greenberg, MD, is a Distinguished Professor of Medicine and Director of the Advanced Heart Failure Treatment Program at the University of California, San Diego (UCSD). He earned a medical degree from the State University of New York Upstate Medical University College of Medicine in Syracuse and completed his internship at George Washington University Hospital and residency in internal medicine at Yale-New Haven Hospital. Following research training at the Lipid Metabolism Branch of the National Heart, Lung, and Blood Institute in Bethesda, Maryland and the Cardiovascular Research Institute of the University of California, San Francisco (UCSF), he completed a fellowship in cardiology at UCSF. He then joined the faculty of Oregon Health Sciences University School of Medicine. Prior to arriving at UCSD, he was visiting professor in residence at the Royal Postgraduate Medical School in London, England and at the Laboratoire de Médicine Expérimentale of the Collège de France in Paris.

Dr. Greenberg’s clinical research focuses on understanding mechanisms of cardiac dysfunction and developing new heart failure therapies. In addition to investigator initiated research, he has served on the executive steering committees of numerous international multicenter heart failure trials. In addition, Dr. Greenberg directs a basic science laboratory that studies the molecular basis of cardiac remodeling, myocardial fibrosis and the development of novel therapies. He has published extensively in medical journals throughout his career.

Dr. Greenberg is co-editor of Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management, the first comprehensive text in this field, now in its 3rd edition and is editor of Myocardial Remodeling: Mechanisms and Treatment, published in 2006 and Management of Heart Failure published in 2010. He served as Associate Editor for the Journal of the American College of Cardiology from 2002-2014 and is a member of the editorial boards of several cardiology and subspecialty journals.

Dr. Greenberg is a founding member and past President of the Heart Failure Society of America (HFSA). He chaired the initial HFSA Heart Failure Board Review Course and he also has served as Chair for numerous HFSA Committees (including Education, Advocacy, Nominating, and Corporate Affairs) and for the Strategic Development initiative in 2010.

Dr. Greenberg is an active clinician and teacher. He has been recognized for many years as being one of the “Best Doctors in America” and “Best Doctors in San Diego.”

Dr. Barbara Riegel is the Edith Clemmer Steinbright Professor of Gerontology at the University of Pennsylvania, School of Nursing and Co-editor of the Journal of Cardiovascular Nursing.

Dr. Riegel’s significant contributions in heart failure (HF) research have systematically addressed the quality and effectiveness of HF management programs, nursing practice, and patient outcomes worldwide. As an internationally acclaimed nurse scientist, Dr. Reigel’s program of research focuses on outcome-based, theory-driven research on self-care of HF. For over 20 years, Dr Riegel has developed, tested and refined a theory of HF self-care that is used extensively nationally and internationally by many other Interprofessional scientists studying HF self-care. She also developed the Self-Care of Heart Failure Index (SCHFI), the first instrument to comprehensively measure self-care in patients with HF. The SCHFI is considered the preeminent measure of self-care in HF, has been translated in 16 languages and used in more than 30 countries around the world demonstrating the global impact of Dr Riegel’s important work. Dr. Riegel’s research has culminated in hundreds of publications and presentations, and she has mentored over 100 students and nurse scientists worldwide.

Dr Riegel’s leadership in HF nursing is recognized through her service on numerous clinical guideline panels and as co-author on more than16 clinical guidelines that are widely cited and are extremely influential in standardizing care for individuals with HF including the 2013 ACCF/AHA Guideline for the Diagnosis and Treatment of Heart Failure. As a member of HFSA since 1997, Dr. Riegel’s has served in numerous ways including important leadership roles as the Co-Chair for the Program Committee, Chair of the Clinical Practice Award Committee, and Nursing Research Award Committee.

Johana Rocio Almansa DNPc, R.N. ANP-BC CHFN immigrated from Colombia, South America at the age of 16 years old. While learning English as a second language, Ms. Almansa graduated with honors with an Associate Degree in Nursing in 1999. After obtaining a Bachelors of Science in Nursing at Florida Atlantic University in 2004, Ms. Almansa joined the open-heart surgery team at Johns Hopkins Hospital, where she participated in the care of Left Ventricular Assist Device and Heart Transplant patients. During her six years working on the cardiac surgery team, Ms. Almansa obtained certification as a Registered Nurse First Assistant, a Post Baccalaureate Certificate in Nursing Education and a Masters of Science in Nursing as an Adult/Gerontology Nurse Practitioner at the University of Maryland. More recently, Ms. Almansa in her role as nurse practitioner helped to start the Heart Failure Bridge Clinic at Johns Hopkins, where she developed an interest in Cardiac Amyloidosis (CAm). While the primary focus of the clinic is to facilitate the transition from the inpatient to the outpatient arenas after discharge, Ms. Almansa created a support group for patients with CAm, becoming part of the national Amyloidosis Support Group Association. Ms. Almansa is a Certified Heart Failure Nurse and currently serves on the Education committee for the American Association of Heart Failure Nurses, the Heart Failure Society of America and the Amyloidosis Foundation. In 2014, Ms. Almansa was awarded the Johns Hopkins Heart of Gold award. Ms. Almansa has also participated in several medical mission trips to Latin America with the Johns Hopkins Cardiac Surgery team as well as the Mision Internacional de Medicos Americanos [MIMA] Foundation.